Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Impaired Colleagues and Providers

Sep 20, 2019/Policies & Bylaws

House position: Outlines expectations for members when addressing problems demonstrated by impaired colleagues and providers.

Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children

May 1, 2020/CPG

These guidelines address the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children, including new guidance on the management of resistant hypertension and the management of hypertension in women planning pregnancy.

2018 State Policy and Payment Form Offers a Packed Agenda

Aug 1, 2018/News

Issues that directly affect PTs, PTAs, and society as a whole—population health, the opioid crisis, innovative delivery models, and much more—will be front and center at the 2018 APTA State Policy and Payment Forum.

Considering Mental and Behavioral Health in Physical Therapy Patient Care

May 13, 2021/Podcast

In this episode, experts explore how the mind and body intersect in the healing process, and how physical therapists and physical therapist assistants can provide better patient care by understanding the body's response to stress and trauma.

APTA Commitment to Increasing Diversity, Equity, and Inclusion

Nov 1, 2021/Policies & Bylaws

Board policy: APTA is committed to increasing diversity, equity, and inclusion in the association, profession, and society.

Peripheral Arterial Disease: Diagnosis and Management [NICE CG147]

Dec 11, 2020/CPG

This guideline provides recommendations related to the diagnosis and management of peripheral arterial disease (PAD) in people aged 18 and over.

Digital Health Technology and Physical Therapy

Apr 15, 2022/Statement

APTA maintains that "physical therapy," whether provided in person or virtually, is performed or directed by licensed physical therapists.

American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine: Evidence-Based Guideline Summary Evaluation, Diagnosis, and Management of Congenital Muscular Dystrophy

Mar 31, 2015/CPG

The objective of the guideline is to delineate optimal diagnostic and therapeutic approaches to congenital muscular dystrophy (CMD) through a systematic review and analysis of available literature.

American Academy of Neurology and American Association of Neuromuscular & Electrodiagnostic Medicine: Evidence-Based Guideline Summary Evaluation, Diagnosis, and Management of Fascioscapulohumeral Muscular Dystrophy

Jul 28, 2015/CPG

Recommendations for the evaluation, diagnosis, prognostication, and treatment of facioscapulohumeral muscular dystrophy (FSHD) from a systematic review and analysis of the evidence.